S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   174.90 (+2.17%)
MSFT   334.66 (-0.08%)
FB   330.35 (+2.34%)
GOOGL   2,964.63 (+0.65%)
AMZN   3,520.40 (-0.08%)
TSLA   1,068.60 (+1.60%)
NVDA   317.85 (-1.98%)
BABA   124.88 (-0.53%)
NIO   34.99 (+5.65%)
CGC   10.93 (+2.73%)
AMD   145.08 (+0.16%)
GE   98.33 (+0.80%)
MU   86.00 (+0.20%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.35 (+1.68%)
PFE   51.39 (-0.64%)
AMC   32.32 (+4.12%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   174.90 (+2.17%)
MSFT   334.66 (-0.08%)
FB   330.35 (+2.34%)
GOOGL   2,964.63 (+0.65%)
AMZN   3,520.40 (-0.08%)
TSLA   1,068.60 (+1.60%)
NVDA   317.85 (-1.98%)
BABA   124.88 (-0.53%)
NIO   34.99 (+5.65%)
CGC   10.93 (+2.73%)
AMD   145.08 (+0.16%)
GE   98.33 (+0.80%)
MU   86.00 (+0.20%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.35 (+1.68%)
PFE   51.39 (-0.64%)
AMC   32.32 (+4.12%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   174.90 (+2.17%)
MSFT   334.66 (-0.08%)
FB   330.35 (+2.34%)
GOOGL   2,964.63 (+0.65%)
AMZN   3,520.40 (-0.08%)
TSLA   1,068.60 (+1.60%)
NVDA   317.85 (-1.98%)
BABA   124.88 (-0.53%)
NIO   34.99 (+5.65%)
CGC   10.93 (+2.73%)
AMD   145.08 (+0.16%)
GE   98.33 (+0.80%)
MU   86.00 (+0.20%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.35 (+1.68%)
PFE   51.39 (-0.64%)
AMC   32.32 (+4.12%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.52 (+0.42%)
AAPL   174.90 (+2.17%)
MSFT   334.66 (-0.08%)
FB   330.35 (+2.34%)
GOOGL   2,964.63 (+0.65%)
AMZN   3,520.40 (-0.08%)
TSLA   1,068.60 (+1.60%)
NVDA   317.85 (-1.98%)
BABA   124.88 (-0.53%)
NIO   34.99 (+5.65%)
CGC   10.93 (+2.73%)
AMD   145.08 (+0.16%)
GE   98.33 (+0.80%)
MU   86.00 (+0.20%)
T   23.17 (+0.39%)
F   19.83 (-0.65%)
DIS   153.35 (+1.68%)
PFE   51.39 (-0.64%)
AMC   32.32 (+4.12%)
ACB   6.59 (+3.29%)
BA   211.05 (+1.06%)
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF Stock Forecast, Price & News

$37.20
+1.01 (+2.79%)
(As of 12/7/2021 12:00 AM ET)
Add
Today's Range
$36.91
▼
$37.42
50-Day Range
$34.21
▼
$38.20
52-Week Range
$28.83
▼
$38.49
Volume
6,895 shs
Average Volume
15,036 shs
Market Capitalization
$16.74 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive BOUT News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD Breakout Opportunities ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BOUT
Inception Date9/13/2018
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkIBD Breakout Stocks Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$16.76 million
Average Daily Volume$10.17 thousand
Discount/Premium-0.05%

ETF Expenses

Management Fee0.80%
Other Expenses0.04%
Total Expenses0.84%
Fee Waiver0.00%
Net Expenses0.84%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of BOUT

Currency Exposure of BOUT

Sector Exposure of BOUT

Industry Exposure of BOUT













Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Frequently Asked Questions

How has Innovator IBD Breakout Opportunities ETF's stock price been impacted by COVID-19?

Innovator IBD Breakout Opportunities ETF's stock was trading at $17.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BOUT stock has increased by 107.7% and is now trading at $37.20.
View which stocks have been most impacted by COVID-19.

What is Innovator IBD Breakout Opportunities ETF's stock symbol?

Innovator IBD Breakout Opportunities ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BOUT."

Who are Innovator IBD Breakout Opportunities ETF's major shareholders?

Innovator IBD Breakout Opportunities ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Citadel Advisors LLC (2.23%), Advisor Group Holdings Inc. (0.60%) and UBS Group AG (0.32%).

Which major investors are buying Innovator IBD Breakout Opportunities ETF stock?

BOUT stock was acquired by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, UBS Group AG, and Advisor Group Holdings Inc..

How do I buy shares of Innovator IBD Breakout Opportunities ETF?

Shares of BOUT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innovator IBD Breakout Opportunities ETF's stock price today?

One share of BOUT stock can currently be purchased for approximately $37.20.

How much money does Innovator IBD Breakout Opportunities ETF make?

Innovator IBD Breakout Opportunities ETF has a market capitalization of $16.74 million.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.